[Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004088:Dihydroergotoxine / Q000627:therapeutic use*; D004176:Dipyridamole / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D004088:Dihydroergotoxine; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone
Approche critique d'un essai thérapeutique sur la prévention secondaire des accidents ischémiques cérébraux par les anti-agrégants.